{"id":32552,"date":"2020-07-28T12:30:44","date_gmt":"2020-07-28T11:30:44","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32552"},"modified":"2023-04-29T13:41:31","modified_gmt":"2023-04-29T12:41:31","slug":"martina-kaufmann","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2017-speakers\/martina-kaufmann\/","title":{"rendered":"Martina Kaufmann"},"content":{"rendered":"
\n\n\t

Martina Kaufmann<\/h2>\n

Managing Director at Martina Kaufmann Strategic Consulting<\/h4>\n\t

Dr. Martina Kaufmann, Managing Director at Martina Kaufmann Strategic Consulting (www.mk-stracon.com<\/a>) has 15+ years industry experience in the field of personalized medicine – from biomarker validation, companion diagnostics development to implementation of such products in the market.<\/p>\n

She served in various roles of increasing responsibility in business and development functions in small biotech \/ diagnostic companies as well as in global pharmaceutical & diagnostics corporations (Hoffmann-La Roche AG, Novartis Pharma AG, Novartis Molecular Diagnostics), where she e.g. led the Herceptin\u00ae biomarker \/ companion diagnostics activities and did build up the oncology biomarker group in Basel, respectively.<\/p>\n

Since April 2012 she is offering her comprehensive and longtime experience as a consultant to an international clientele in both pharma and diagnostics industry.<\/p>\n

Her services range from strategic concept development to project specific consulting for CDx development under consideration of strategic, scientific, regulatory, operational and commercial aspects.<\/p>\n

In addition, she\u00b4s contributing to personalized medicine conferences and giving lectures in personalized medicine (ETH Zurich, University of Heidelberg).<\/p>\n\t\t\t\t\t\t\t\"Martina\t\t\t\t\t\t\t\n

\n\tTitle: Companion diagnostics – recent advances and future perspectives\n\t<\/h3>\n